ABSTRACT
INTRODUCTION
Growth is a substantial part of human life. The infant stage of human life has a pivotal role in the growth and development. It is observed to have maximum growth rate during this phase. Provision of optimal nutrition during this period of life is an essential requirement as it aids in the proper growth and development of the infant.
Breastfeeding plays an important role in providing nutrition to the infants. It has been highly recommended to breastfeed infants in the first 6 months of life. The World Health Organization (WHO), the American Academy of Pediatrics (AAP), the American College of Obstetricians and Gynecologists (ACOG), and the United States Preventive Services Task Force all recommend exclusive breastfeeding for the first 6 months of life. [1] [2] [3] [4] Breastfeeding for all infants is strongly supported by both governmental and medical professional organizations because of its acknowledged benefits with respect to nutrition, gastrointestinal function, host defense and psychological well-being.
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Ironically, in spite of knowing the importance of breastfeeding, and following decades of strategies and tactics in tackling this issue, there is much left to be achieved in reaching the optimum level on a national scale when it comes to breastfeeding. The numbers show that an abysmal 46% mothers practice exclusive breastfeeding (EBF).
9
Early breastfeeding initiation was noted only in 40.4%. 9 A major reason for this low numbers has been attributed to a new condition called insufficient milk syndrome (IMS).
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Insufficient milk production could be the result of a number of predisposing factors. This usually affects the quality of life of these mothers that can undermine their confidence and elevate anxiety.
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Corporate marketing and readily available formula feeds may hamper breastfeeding. The use of formula feeds might be due to many reasons like perceived insufficient milk production, physical barriers, inability to breastfeed at workplace or even as a status symbol owing to the perception JSAFOG in developing countries that formula feeds are better than breast milk.
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Premature infants have greater nutritional needs to achieve optimal growth in the neonatal period than at any other time of their life. Nutritional support helps to correct growth restriction at birth and to achieve an appropriate rate of weight gain, which is almost twice that of a term infant. 13, 14 However, this is rendered difficult due to many factors. A major impediment to exclusive human milk feeding for premature infants is the difficulty many mothers experience in providing sufficient quantities of milk. The reasons cited for this are emotional stress, difficulty in maintaining supply without a suckling infant, or the biological immaturity of the mammary glands of mothers of premature neonates. Also under nourished mother does not supply sufficient quantities of nutrients, such as protein, calcium, phosphorus, iron and vitamins. 15 Though nowadays mothers are shifting over to elective cesarean section (C-section) instead of vaginal deliveries, it is not without its own disadvantages. Studies have shown that C-sections can lead to inadequate breastfeeding. Since C-section is associated with infections, atopic disease, obesity, hypertension and diabetes mellitus, it is possible that this may indirectly predispose to conditions, such as reduced breast milk production. 16 In addition, the national guidelines have also highlighted the importance of anintake of >550 calories for the lactating mother apart from the normal intake to sustain the needs of both mother as well as the infant. 17 In India, owing to the traditional and cultural practices, the nutrition of the lactating mother remains a concern, which in turn affects the quantity and quality of milk to be fed to the infant. Nutritional requirements to support lactation are high and the requirements for many components are greater in lactating women than in those in the nonpregnant state. 18 Requirements for energy, protein, vitamins A, C, E, B 6 , B 12 , folate, niacin, riboflavin and thiamine, and the minerals iodine, selenium and zinc are increased in lactating women. The additional protein requirement for the first 6 months of lactation is 25 gm/day.
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The current scenario of reduced nutrition in mothers and insufficient breast milk to the infants has led to the formulation of a novel preparation that can aid in meeting this deficiency by nurturing the mother.
Recently, marketed novel preparation that contains the necessary ingredients which nurtures mother as well as increase the milk production along with an increase in the nutritional status of the milk. These ingredients include essential vitamins, minerals, carbohydrates, proteins, fats, sugar, dietary fibers, docosahexaenoic acid (DHA) and galactogogues.
These ingredients have been observed to improve the milk production when used individually as well as in combination. Thus, this combination of all the necessary supplements is beneficial in providing the necessary nutrition to the infant that is deserved without compromising the mother's health.
A post-marketing surveillance (PMS) study was undertaken to evaluate the efficacy of combination of galactagogue, minerals, carbohydrate, protein, dietary fiber, etc. in a large population.
OBJECTIVE
A large PMS study intended to evaluate the efficacy of galactagougue, vitamins, minerals, dietary fibers, carbohydrate, protein combination in terms of quantitative improvement of mother's milk, patient satisfaction, compliance and growth of the infant due to additional nutrition owing to the intake of the said formulation by the mother was conducted. Parameters like quantitative improvement in milk, infant growth, patient satisfaction and patient compliance were assessed in order to evaluate the efficacy and compliance of galactagogue combination in this population.
MATERIALS AND METHODS
A multicentric, noncomparative study was conducted in patients spread across the country. This study included mothers with inadequate or no breast milk at the time of delivery, and also mothers who had preterm delivery, associated with inadequate milk production. The patients were advised 30 gm of lactancia powder twice daily along with lukewarm water or milk for at least a month to assess the efficacy.
Group 1 included mothers who had no or inadequate milk production, while group 2 consisted of mothers with suboptimal level milk production or had underweight infants.
The main efficacy outcome assessed in the study included improvement in body weight of the infant observed with the use of galatoctogue and combination (Lactancia from Corona Remedies Pvt. Ltd.) by the mother after 30 days of treatment. Additionally, parameters with regards to lactation were recorded intermittently to assess improvements after 3, 5 or 7 days respectively. Also, the improvement in lactation after a period of 30 days was assessed.
RESULTS
A total of 1,132 patients were involved in the study. It was observed that 549 mothers had delivered vaginally and 486 mothers underwent cesarean. The categorization of the patients based on the quantity of the milk production was done as per clinical examination. Thus, 45.4% mothers who had inadequate lactation were categorized under group 1, and 42.7% of the mothers who had proper lactation were categorized under group 2 (Graph 1).
It was observed to improve lactation in 1,049 patients within a span of week. Out of that, 492 patients have reported to increased lactation in 3 days of treatment as shown in Graph 2.
Ninety percent patients having at least a good improvement and 45% patients with an excellent improvement as shown in Graph 3. A similar observation was also made with reference to patient compliance, which revealed that 90% patients had at least a good compliance after supplementation.
The trend in increase in body weight in infants was consistent in comparison to other observations, such as improvement in lactation and patient satisfaction. The bodyweight increased by 600 gm taking into consideration the whole of the study population. Also, a similar trend was observed when subpopulations were taken into consideration as shown in Graph 4.
Among the mothers who had delivered through C-section, it was noted that 223 (46%) mothers had an excellent improvement in lactation following administration of studied formulation, while 229 (47%) mothers had a good improvement with lactancia. Only 13 (3%) mothers were noted to have poor or no improvement in lactation at the end of 30 days (Graph 5).
The weight gain in infants was analyzed. The mean weight before starting treatment was 2.69 kg, while the mean weight after a month was noted to 3.4 kg (Graph 6).
Low birth weight (LBW) infants (defined as birth weight of <2.5 kg) and very low birth weight (VLBW) infants (defined as <1.5 kg birth weight) 19 were also assessed with regards to weight before initiation of lactancia and after 30 days of treatment. In the LBW infants, the mean weight had increased from 2.29 to 3.04 kg, while in the VLBW, the mean weight increased from 1.41 to 2.3 kg (Graph 7).
SUMMARY
These results make it evident that the infants gained weight as required, irrespective of the conditions prevalent in the mother, with the use of lactancia. This was supplemented by the fact that they were very well tolerated, had very minimal safety issues and the compliance was very high. Lactancia is beneficial in the treatment of IMS and also in other cases where there is insufficient production of milk by the mother. Thus, the requirement for the extra nutrition necessary to breastfeed the infant in the recommended time period of 6 months can be met with the regular usage of lactancia.
CONCLUSION
Lantancia can be good alternative supplementation to mother's of low birth babies which help infant to grow rapidly. Based on the study, lactancia is effective supplementation for the lactating mothers.
